Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Allogeneic Hematopoietic Stem Cell Transplantation for ERCC6L2 disease

Closed Survey/Study

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Ulla Wartiovaara-Kautto, Outi Kilpivaara and Flore Sicre de Fontbrune

Allogeneic HSCT in ICU setting

Closed Survey/Study

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Tayfun Güngör

Impact of body mass index on outcome of CART cell therapy

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Christian Schultze-Florey

Survey on the use of SGLT2 inhibitors in cell therapy including autologous and allogeneic hematopoietic stem cell transplantation and CART cell therapy

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Christian Schultze-Florey

Setting the stage for newborn screening and gene therapy: a disease-specific retrospective survey of FHL2 and 3

Études rétrospectives

Troubles héréditaires

Inborn Errors Working Party (IEWP)

Type de traitement

Investigateur principal

Stephan Ehl, Despina Moshous, Claire Booth, Sujal Ghosh

Evaluation of Outcomes following Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with High-Risk Acute Myeloid Leukemia:

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogénique - Apparentée

Allogénique - Non apparentée

Allogénique - Haplo-identique

Investigateur principal

Akshay Sharma (Memphis, US)

Long-term survival after autologous or allogeneic transplantation for T-cell lymphoma: a retrospective analysis of the EBMT-Lymphoma Working Party

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Outcomes of Autologous and Allogeneic Stem Cell Transplantation in Patients with Hepatosplenic T-cell Lymphoma (HSTCL)

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Imke E. Karsten

Allogeneic Hematopoietic Cell Transplantation and CAR-T therapy for T-cell/histiocyte-rich Large B-cell Lymphoma (THRLBCL) A Retrospective Study of the EBMT Lymphoma Working Party

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Simon Renders, MD

Trends in Hematopoietic Stem Cell Transplantation for Patients with Diffuse Large B-Cell Lymphoma. A Retrospective Analysis of the Lymphoma WP of the EBMT

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Norbert Schmitz, Anna Sureda

Efficacy and toxicity of CAR T cell therapy in patients with primary and secondary central nervous system lymphoma

Études rétrospectives

Lymphome non hodgkinien (LNH)

GoCART Coalition

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Anna Ossami Saidy

Post-transplantation cyclophosphamide-based after HLA-matched versus haploidentical donor transplants in patients with Hodgkin lymphoma: a comparative study of the LWP EBMT

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Allogénique - Haplo-identique

Investigateur principal

Dr. Juan Montoro